Form D · Biotechnology
Guide Star Biosciences, Inc.
Del Mar, CA · CIK 0002150891
Offering snapshot reported Aug 18, 2026 · SEC filing
- Reported sold
- $925K Offering amount: $1.2M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Aug 13, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 18, 2026 | Initial | $925,000 | No comparison | 12 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-594597
Source: Form D, filed Aug 18, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Eli N. Glezer | Director, Executive |
| Daan Witters | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
13746 Durango Drive
Del Mar, CA, 92014
Phone: (240) 305-8868
Del Mar, CA, 92014
Phone: (240) 305-8868